Quantification of Survival Gain From Cardiac Resynchronization Therapy: Nonlinear Growth With Time, and Greater Gain in Low-Risk Patients, Make Raw Trial Data an Underestimate of Real-World Behavior

OBJECTIVES: The goal of this study was to examine the impact of calculation-window duration on lifespan gain (as observed in trials) and on who gains most. BACKGROUND: The landmark trials of biventricular pacing (cardiac resynchronization therapy [CRT]) typically ran for <1 device battery life, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Finegold, Judith A., Raphael, Claire E., Levy, Wayne C., Whinnett, Zachary, Francis, Darrel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Biomedical 2013
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866660/
https://www.ncbi.nlm.nih.gov/pubmed/23988700
http://dx.doi.org/10.1016/j.jacc.2013.07.080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866660/
https://www.ncbi.nlm.nih.gov/pubmed/23988700
http://dx.doi.org/10.1016/j.jacc.2013.07.080

Ejemplares similares